Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma

被引:41
作者
Piao, Z
Choi, Y
Park, C
Lee, WJ
Park, JH
Kim, H
机构
[1] YONSEI UNIV,COLL MED,DEPT PATHOL,SEOUL,SOUTH KOREA
[2] YONSEI UNIV,COLL MED,DEPT GEN SURG,SEOUL,SOUTH KOREA
[3] YONSEI UNIV,COLL MED,DEPT MICROBIOL,SEOUL,SOUTH KOREA
关键词
M6P/IGF2; receptor; hepatocellular carcinoma; tumor suppressor gene;
D O I
10.1016/S0304-3835(97)00289-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To evaluate the different alteration patterns of the mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2r) gene in hepatocellular carcinoma (HCC), 41 HCCs were screened for homozygous deletion and loss of heterozygosity (LOH) at the M6P/IGF2r gene with a dinucleotide repeat polymorphic marker. Of these, three (8.8%) were heterozygous and LOH was observed in two (66.7%) of these informative cases. Five (14.7%) out of 34 informative cases showed homozygous deletions for the dinucleotide repeat polymorphic marker. The frequent allelic loss and homozygous deletion of the M6P/IGF2r gene suggest that the M6P/IGF2r gene functions as a tumor suppressor gene in the development of HCC. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 32 条
[1]   LOSS OF HETEROZYGOSITY SUGGESTS TUMOR SUPPRESSOR GENE RESPONSIBLE FOR PRIMARY HEPATOCELLULAR-CARCINOMA [J].
BUETOW, KH ;
MURRAY, JC ;
ISRAEL, JL ;
LONDON, WT ;
SMITH, M ;
KEW, M ;
BLANQUET, V ;
BRECHOT, C ;
REDEKER, A ;
GOVINDARAJAH, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8852-8856
[2]   CELLULAR ACTIVATION OF LATENT TRANSFORMING GROWTH-FACTOR-BETA REQUIRES BINDING TO THE CATION-INDEPENDENT MANNOSE 6-PHOSPHATE INSULIN-LIKE GROWTH-FACTOR TYPE-II RECEPTOR [J].
DENNIS, PA ;
RIFKIN, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :580-584
[3]   M6P/IGF2R GENE IS MUTATED IN HUMAN HEPATOCELLULAR CARCINOMAS WITH LOSS OF HETEROZYGOSITY [J].
DESOUZA, AT ;
HANKINS, GR ;
WASHINGTON, MK ;
ORTON, TC ;
JIRTLE, RL .
NATURE GENETICS, 1995, 11 (04) :447-449
[4]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
[5]  
2-E
[6]  
FUJIMORI M, 1991, CANCER RES, V51, P89
[7]  
FUJIMOTO Y, 1994, CANCER RES, V54, P281
[8]   DELETIONS INVOLVING 2 DISTINCT REGIONS OF 6Q IN B-CELL NON-HODGKIN LYMPHOMA [J].
GAIDANO, G ;
HAUPTSCHEIN, RS ;
PARSA, NZ ;
OFFIT, K ;
RAO, PH ;
LENOIR, G ;
KNOWLES, DM ;
CHAGANTI, RSK ;
DALLAFAVERA, R .
BLOOD, 1992, 80 (07) :1781-1787
[9]   DINUCLEOTIDE REPEAT POLYMORPHISM AT THE IGF2R LOCUS [J].
GOTO, J ;
FIGLEWICZ, DA ;
MARINEAU, C ;
KHODR, N ;
ROULEAU, GA .
NUCLEIC ACIDS RESEARCH, 1992, 20 (04) :923-923
[10]  
HAHN SA, 1995, CANCER RES, V55, P4670